Table 1. Baseline Characteristics
| Variable |
Variable |
BMI <30 (n = 222) |
BMI ≥30 (n = 154) |
p-value |
| n |
222 |
154 |
|
|
| Age (mean ± SD) |
49.54 (16.91) |
51.74 (15.51) |
0.199 |
|
| ASA (%) |
|
|
<0.001 |
|
| 1 |
12 (5.4) |
2 (1.3) |
|
|
| 2 |
158 (71.2) |
81 (52.6) |
|
|
| 3 |
50 (22.5) |
70 (45.5) |
|
|
| 4 |
2 (0.9) |
1 (0.6) |
|
|
| Sex = Male/Female (%) |
54/168 (24.3/75.7) |
43/111 (27.9/72.1) |
0.507 |
|
| ASA_1 = Yes (%) |
12 (5.4) |
2 (1.3) |
0.073 |
|
| ASA_2 = Yes (%) |
158 (71.2) |
81 (52.6) |
<0.001 |
|
| ASA_3 = Yes (%) |
50 (22.5) |
70 (45.5) |
<0.001 |
|
| ASA_4 = Yes (%) |
2 (0.9) |
1 (0.6) |
1.000 |
exact |
| Indication (% Malignant) |
115 (51.8) |
97 (63.0) |
0.041 |
|
| HTN = No (%) |
175 (78.8) |
87 (56.5) |
<0.001 |
|
| Diabetes = No (%) |
210 (94.6) |
128 (83.1) |
0.001 |
|